CELLINK to acquire Ginolis for EUR 70M

CELLINK AB has agreed to acquire all shares of Ginolis Oy, a Finnish diagnostics automation and robotics company, for EUR 70 million on a cash- and debt-free basis. The acquisition will strengthen CELLINK's bioconvergence position.

“CELLINK has entered into an agreement with the shareholders of Ginolis Oy to acquire all shares for a purchase price on cash- and debt-free basis of 70M euros.”news.cision.com

• 1 source
• news.cision.comCELLINK has entered into an agreement to acquire the advanced robotics and diagnostics automation company Ginolis - BICO GroupFeb 15, 2021

Summarized from public sources; check the original articles before acting on it.